Correlation Between Edgewise Therapeutics and Qiagen NV

Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Qiagen NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Qiagen NV into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Edgewise Therapeutics and Qiagen NV, you can compare the effects of market volatilities on Edgewise Therapeutics and Qiagen NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Qiagen NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Qiagen NV.

Diversification Opportunities for Edgewise Therapeutics and Qiagen NV

-0.5

Correlation Coefficient

Edgewise Therapeutics  Qiagen NV

Very good diversification

The 3 months correlation between Edgewise and Qiagen is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Qiagen NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qiagen NV and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Qiagen NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qiagen NV has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Qiagen NV go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and Qiagen NV

Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Qiagen NV. In addition to that, Edgewise Therapeutics is 4.2 times more volatile than Qiagen NV. It trades about -0.09 of its total potential returns per unit of risk. Qiagen NV is currently generating about 0.14 per unit of volatility. If you would invest  4,343  in Qiagen NV on October 6, 2024 and sell it today you would earn a total of  154.00  from holding Qiagen NV or generate 3.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Edgewise Therapeutics  vs.  Qiagen NV

Edgewise Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Edgewise Therapeutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Qiagen NV

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Qiagen NV are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical and fundamental indicators, Qiagen NV is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Edgewise Therapeutics and Qiagen NV

The main advantage of trading using opposite Edgewise Therapeutics and Qiagen NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Qiagen NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will offset losses from the drop in Qiagen NV's long position.

The idea behind Edgewise Therapeutics and Qiagen NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.